RoundTable seals $403m pharmaceutical exit

The firm’s sale of Aqua Pharmaceuticals marks RoundTable’s third exit from its $500m Fund II.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this